Xenon Pharmaceuticals Inc
Symbol: XENE (NASDAQ)
41.88
▼ (-2.70%) -1.160
Company Description:
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Key Stats
- Today's Open: $42.87
- Today's High: $43.345
- Today's Low: $41.77
- Today's Volume: 639.73K
- Yesterday Close: $43.04
- Yesterday High: $43.84
- Yesterday Low: $42.41
- Yesterday Volume: 714.07K
- Last Min Volume: 6
- Last Min High: $41.88
- Last Min Low: $41.88
- Last Min VWAP: $41.88
Company Profile
- Name: Xenon Pharmaceuticals Inc
- Website: https://www.xenon-pharma.com
- Listed Date: 2014-11-05
- Location: BURNABY,
- Market Status: Active
- CIK Number: 0001582313
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.32B
- Round Lot: 100
- Outstanding Shares: 77.11M
- Asset Type: CS
RECENT FILINGS FOR XENE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | 4 | View |
| 2025-10-17 | 3 | View |
| 2025-10-17 | 8-K/A | View |
| 2025-10-16 | 8-K | View |
| 2025-10-01 | 4 | View |
| 2025-10-01 | 144 | View |
| 2025-09-19 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-03 | 8-K | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 3 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
Latest News on XENE